Attract talent, choose the right profiles, ensure team cohesion, grow human capital: the HR strategy is a key ingredient in the success of the entrepreneurial adventure, at every stage of development. It is however often overlooked in start-ups when all the attention is turned towards technological development and fund raising. Negligence can become a flaw in the scale-up phase. What is an HR strategy, why should it be defined from the first investments, how to do it and what are the benefits?
Analysis and experience sharing, this roundtable will bring together biotech executives, HR strategy expert, and life sciences investor and will be led by Pierre-Louis Germain, journalist, and editor-in-chief of Biotech Finances.
Speakers
Co-founder EXELIOM BIOSCIENCES
Benjamin Hadida co-founded Nextbiotix in December 2016 and has served as Chief Executive Officer since. Benjamin is an entrepreneur who developed a wide range of competences in various industries : investment banking (UBS), venture capital (Pacific Channel), pharmaceutical regulatory affairs (Amgen), biotech operations (Theravectys), applied research (Vision Institute in Paris).
Senior Consultant at Gensearch Consulting
Pauline joined GenSearch in 2011 as a Life Sciences specialist, after twenty successful years in this sector. With a background in biology, Pauline has a passion for an in-depth understanding of Life Science projects, with a view to provide actionable advice. She managed to transform this fundamental interest into a career in Human Resources, convinced that the human factor is the key success factor to any Life Science challenge.
Associate Director Andera Partners
Raphaël joined Edmond de Rothschild Investment Partners in 2001. He worked first at Générale de Santé in London in the financial department before joining the Corporate Finance business in the Healthcare sector at Salomon Smith Barney and at Goldman Sachs.
General Director Sensorion
Nawal Ouzren started at Baxter where she was Operations Manager, then Quality Director and Strategy Director, before becoming Vice President of the Group. BioSimilars division. In 2014, she became Vice President of the Global Hemophilia Division at Baxalta, which became part of the Shire Group. In 2016, she led the Shire Group’s Global Genetic Diseases division.Relive the event
Last events
Event
Afterwork: Key Takeaways from JP Morgan’s Annual Healthcare Conference 2024 in Neighborhood
After two years of turmoil, tough financing, pipeline slimming and cost-cutting… prospects finally look brighter for the…
Event
The Neighborhood Showcase 2023 in Neighborhood
After a year of hard work on producing their development plans and regulatory strategy, Neighborhood’s Start-up Class of 2023 will…
Event
Afterwork: AI a revolution for Healthtech development and Investment? in Neighborhood
AI and in silico models are set to revolutionize biotech investments and transform the entire health innovation ecosystem, join us…
Event
Afterwork: Seen & Heard, Last Week, at JP Morgan’s Annual Healthcare Conference 2023 in Neighborhood
Rising interest rates have triggered a fall in market valuation, and an indirect brutal loss in appetite from VC and…
We'd love to get to know you
Join us, we offer you an extraordinary chance to learn, to develop and to be part of an exciting experience and team.
Tell us your story